Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography
Susanne Keiding, Søren B. Hansen, Henrik H Rasmussen, Antony Gee, Aksel Kruse, Klaus Roelsgaard, Ulrik Tage‐Jensen, Jens Frederik Dahlerup – 30 December 2003 – Primary sclerosing cholangitis (PSC) predisposes to cholangiocarcinoma (CC), which usually is widespread in the liver at the time of the diagnosis and which has a median survival of approximately 6 months. Positron emission tomography (PET) is a noninvasive scanning method that allows the assessment of metabolism in vivo by means of positron‐emitting radiolabeled tracers.